Many people combine it with other medications, supplements, or lifestyle interventions
According to the FDA submission for Wegovy approval (the weight loss medication produced by NovoNordisk that contains the active ingredient semaglutide), the average weight loss over 1 year and 4 months was 15.1%
Some people are more sensitive to the gastric peptides that the medication increases than others, which can cause nausea, stomach pain, or a feeling of being sick
The Peptide InnOvatioN for Early diabEtes tReatment (PIONEER) phase 3 programme demonstrated the efficacy of oral semaglutide versus placebo and active comparators (including empagliflozin, sitagliptin and liraglutide) in achieving glycaemic control and weight loss, with a safety profile consistent with the GLP-1RA drug class [1021]
Compounded semaglutide was often marketed as a more affordable alternative to FDA-approved medications like Ozempic and Wegovy